FA
CEMI

Friess Associates’s Chembio diagnostics, Inc. CEMI Stock Holding History

Friess Associates’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-144,084
Closed -$506K – 123
2021
Q1 		$506K Sell
144,084
-410,916
-74% -$2.29M 0.2% 73
2020
Q4 		$2.64M Buy
+555,000
New +$2.87M 0.19% 77
2020
Q2 		– Sell
-257,000
Closed -$1.32M – 145
2020
Q1 		$1.32M Buy
+257,000
New +$1.04M 0.13% 89

Other funds holding CEMI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Friess Associates's CEMI Position: Q2 2021 in Review

Friess Associates sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 144,084 shares — an estimated $506K sold.

Friess Associates first reported a position in CEMI in Q1 2020 and held it in 3 quarters. The position peaked at $2.64M in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

  • Friess Associates reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Friess Associates sold 144,084 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $506K.
  • Friess Associates first reported a position in Chembio diagnostics, Inc. in Q1 2020 and held it in 3 quarters.
  • Friess Associates's Chembio diagnostics, Inc. position peaked at $2.64M in Q4 2020.
  • 60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Friess Associates's 13F filing for Q2 2021, filed 11 Aug 2021.